What Does Natera Do?

Total employees4462
HeadquartersAustin
Founded2004

Natera is a global leader in cell-free DNA (cfDNA) testing and genetic diagnostics. The company is dedicated to transforming disease management worldwide by harnessing the power of cfDNA to provide early and accurate insights. Natera's portfolio spans women's health (including non-invasive prenatal testing with Panorama®), oncology (with products like Signatera™ for molecular residual disease monitoring and personalized cancer treatment guidance), and organ health (assessing organ transplant rejection risk with Prospera™). They emphasize rigorous scientific validation, technological innovation, and a commitment to improving patient outcomes through accessible and actionable genetic information.

Where Is Natera's Headquarters?

HQ Function

The Austin headquarters serves as the central command for Natera's global operations, housing executive leadership, research and development, corporate strategy, and administrative functions.

Notable Features:

The facility is a state-of-the-art building featuring advanced laboratory spaces, collaborative workspaces, and infrastructure designed to support cutting-edge genetic research and development.

Work Culture:

Natera fosters a mission-driven work culture focused on scientific excellence, innovation, and patient impact. The environment is typically fast-paced, collaborative, and encourages employees to contribute to advancements in genetic healthcare.

HQ Significance:

Relocating its headquarters to Austin allows Natera to tap into a rich talent pool, benefit from a favorable business environment, and expand its R&D and operational capabilities to support its global growth.

Values Reflected in HQ: The headquarters' design and functionality reflect Natera's core values of innovation, scientific rigor, patient focus, and collaboration, aiming to create an environment conducive to groundbreaking work.

Location:

Natera has a significant global presence, offering its genetic testing services in numerous countries worldwide. This is achieved through a combination of direct sales forces, partnerships with distributors, and collaborations with international laboratories and healthcare institutions. Their tests are utilized by clinicians globally to support decision-making in women's health, oncology, and organ transplantation, making advanced genetic insights accessible to a broad patient population.

Street Address:

13011 McCallen Pass

City:

Austin

State/Province:

Texas

Country:

USA

Where Else Does Natera Operate Around the World?

San Carlos, California/USA

Address: 201 Industrial Rd, Suite 410, San Carlos, CA 94070

Serves as a major West Coast operational and R&D center, leveraging proximity to Silicon Valley's talent and biotech ecosystem for collaborations and technological advancements.

Leiden, Netherlands

Address: Zernikedreef 8, 2333 CL Leiden, Netherlands

Manages Natera's expansion and presence in Europe, Middle East, and Africa (EMEA), ensuring compliance with regional standards and catering to local market needs in genetic testing.

Buying Intent Signals for Natera

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Natera? Meet the Executive Team

As of April 2025, Natera' leadership includes:

Steve Chapman - Chief Executive Officer
Michael Brophy - Chief Financial Officer
Solomon Moshkevich - President, Clinical Diagnostics
John Fesko - President and Chief Business Officer
Daniel Rabinowitz - Chief Legal Officer and Corporate Secretary
Sheena Graham - Chief People Officer
Minetta Liu, MD - Chief Medical Officer, Oncology

Who's Investing in Natera?

Natera has been backed by several prominent investors over the years, including:

Sequoia Capital
Claremont Creek Ventures
Lightspeed Venture Partners
OrbiMed
Sofinnova Ventures
Longitude Capital
Casdin Capital
ArrowMark Partners

What Leadership Changes Has Natera Seen Recently?

Hire2
Exits0

Natera has maintained relative stability in its core executive team while making strategic additions to strengthen key areas. In the past year, notable appointments have focused on enhancing medical leadership in oncology and bolstering legal and business operations. No high-profile departures from the C-suite have been publicly announced, indicating continuity in strategic direction.

New Appointments:

Minetta Liu, MD, Dr. Minetta Liu was appointed as Natera's Chief Medical Officer for Oncology, bringing deep expertise in cancer genomics, clinical research, and patient care to lead the company's medical strategy in the oncology sector.
Daniel Rabinowitz, Daniel Rabinowitz joined Natera as Chief Legal Officer and Corporate Secretary, tasked with overseeing the company's global legal affairs, corporate governance, and compliance programs.

What Technology (Tech Stack) Is Used byNatera?

Discover the tools Natera uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Natera Email Formats and Examples

Natera commonly uses the [first_initial][last_name]@natera.com email format for its employees. While other formats might exist in isolated cases, this is the predominant structure observed for professional communications.

flastname@natera.com (e.g., jdoe@natera.com)

Format

schhapman@natera.com

Example

90%

Success rate

What's the Latest News About Natera?

GlobeNewswireMay 16, 2024

Natera and Personalis Announce Collaboration to Develop Personalized MRD Assays for Pharma Partners

Natera, Inc. and Personalis, Inc. announced a collaboration to develop personalized, tumor-informed molecular residual disease (MRD) assays for pharmaceutical partners. The collaboration aims to combine Natera's Signatera technology with Personalis' NeXT Personal liquid biopsy assay to offer enhanced MRD testing solutions for cancer therapy development....more

Natera Investor RelationsMay 7, 2024

Natera Reports First Quarter 2024 Financial Results

Natera announced its financial results for the first quarter ended March 31, 2024. The company reported total revenues of $301.8 million, a 29% increase compared to the first quarter of 2023. They also highlighted strong test volume growth, particularly in oncology and women's health....more

GlobeNewswireApril 8, 2024

Natera Presents New Data Across Multiple Tumor Types at AACR 2024, Further Validating Signatera’s Prognostic and Predictive Value

Natera presented 18 abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2024. The data highlighted the clinical utility of its Signatera MRD test in various cancers, including its ability to predict treatment response, monitor for recurrence, and inform adjuvant therapy decisions....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Natera, are just a search away.